Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Karyopharm Therapeutics (25K0.STU) Q1 2026 Earnings
25K0.STU
12
Feb
Confirmed
Q1 2026
-4.81
-3.77
-2.72
-1.68
Details
Expected EPS
-1.6802657264399998
Actual EPS
-4.8109034
Surprise EPS
-3.13
Surprise Percent
+186.32%
Description
Karyopharm Therapeutics (25K0.STU) has reported earnings of -4.8109034 per share for Q1 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login